Speakers: Emmett Sprecher, Team leader of data science at Olink proteomics
Original Broadcast date: March 25 2021
Today’s drug development biomarker and genetic pathway researchers know how difficult proteomics analysis has traditionally been. Recent developments in a scalable and highly multiplexed protein assay have been coupled with an online tool to make significant results easily stand out for further characterization.
In this webinar, Emmett Sprecher explains how Olink’s normalized protein expression values (NPX) can be easily analyzed with the online Olink Insights tool, utilizing a public dataset of COVID-19 protein expression data from patient plasma samples to demonstrate the analyses. In addition, he showcases single-cell RNA-seq dataset alongside its plasma proteome from melanoma immunotherapy-treated patient samples.
If you have any questions about Olink, please contact us at info@olink.com.